These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25901194)

  • 1. ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics.
    Su D; Katsaros D; Xu S; Xu H; Gao Y; Biglia N; Feng J; Ying L; Zhang P; Benedetto C; Yu H
    Am J Transl Res; 2015; 7(2):242-56. PubMed ID: 25901194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
    Wakinoue S; Chano T; Amano T; Isono T; Kimura F; Kushima R; Murakami T
    Cancer Biomark; 2019; 24(2):223-229. PubMed ID: 30594917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
    Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
    Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3.
    Chen Q; Fu WJ; Tang XP; Wang L; Niu Q; Wang S; Lin Y; Cao MF; Hu R; Wen HY; Wang Y; Zhang X; Yao XH
    J Cancer; 2021; 12(3):818-826. PubMed ID: 33403039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
    Chen X; Su Z; Wang S; Xu H
    Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the metastasis-associated genes and its copy numbers variation in highly metastatic epithelial ovarian cancer].
    Ying LS; Xu SH; Su D; Mou HZ; Gu LH; Zhu CH; Liu XL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):126-30. PubMed ID: 19570424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF3 Demethylation Promotes the Transcription of ARL4C, Which Acts as a Tumor Suppressor in Human Breast Cancer.
    Li L; Sun RM; Jiang GQ
    Onco Targets Ther; 2020; 13():3467-3476. PubMed ID: 32425548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions.
    Chen X; Zhang Y; Qian W; Han L; Li W; Duan W; Wu Z; Wang Z; Ma Q
    iScience; 2021 Dec; 24(12):103400. PubMed ID: 34849465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.
    Qu W; Chen X; Wang J; Lv J; Yan D
    Clin Chim Acta; 2017 Oct; 473():237-244. PubMed ID: 28698064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip.
    Xu S; Mou H; Lü G; Zhu C; Yang Z; Gao Y; Lou H; Liu X; Cheng Y; Yang W
    Chin Med J (Engl); 2002 Jan; 115(1):36-41. PubMed ID: 11930655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP-ribosylation factor-like 4C binding to filamin-A modulates filopodium formation and cell migration.
    Chiang TS; Wu HF; Lee FS
    Mol Biol Cell; 2017 Nov; 28(22):3013-3028. PubMed ID: 28855378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphyllin I inhibits proliferation and metastasis of ovarian cancer cell line HO-8910PM in vitro.
    Gu L; Feng J; Xu H; Luo M; Su D
    J Tradit Chin Med; 2013 Jun; 33(3):325-33. PubMed ID: 24024328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of cantharidin on invasion and metastasis of highly metastatic ovarian carcinoma cell line HO-8910PM].
    He TP; Mo LE; Liang NC
    Ai Zheng; 2005 Apr; 24(4):443-7. PubMed ID: 15820067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARL4C depletion suppresses the resistance of ovarian cancer to carboplatin by disrupting cholesterol transport and autophagy
    Yang J; Peng S; Zhang K
    Hum Exp Toxicol; 2022; 41():9603271221135064. PubMed ID: 36366750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro].
    Qin YM; Li K; He TP; Mo LE; Liang NC
    Zhong Yao Cai; 2007 Feb; 30(2):176-8. PubMed ID: 17571767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma.
    Isono T; Chano T; Yoshida T; Makino A; Ishida S; Suzaki M; Kageyama S; Kawauchi A; Yonese J; Yuasa T
    Am J Cancer Res; 2019; 9(2):415-423. PubMed ID: 30906638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.